日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers

解读上皮性卵巢癌脑转移：多模态分析和潜在生物标志物

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01206-y
Trozzi, R; Salvi, M; Karimi, M; Minucci, A; Raspaglio, G; De Donato, M; Buttarelli, M; Piermattei, A; Vaccaro, L; Grimaldi, A; De Santis, R; Massa, M; Sillano, F; Giacò, L; Mastrantoni, L; Iacobelli, V; Camarda, F; Cesana, M; Duranti, S; Sassu, M C; Mattogno, P; Fagotti, A; Marchetti, C; Scambia, G; Nero, C; Cacchiarelli, D
肿瘤
肿瘤免疫
神经科学
卵巢癌
发表日期：2026
文献求助 收藏

Fibroblast growth factor signaling induces a chondrocyte-like state of peripheral nerve fibroblast during aging.

成纤维细胞生长因子信号传导在衰老过程中诱导周围神经成纤维细胞呈现软骨细胞样状态。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-65297-8
Stefanovska Dragana, Sassu Eliza, Tekman Mehmet, Naghsh Nilchi Amirhossein, Haider Severin, Domisch Claudia, Hossfeld Madelon, Perez-Feliz Stefanie, Miarka Lauritz, Schneider-Warme Franziska, Arnold Sebastian J, Prinz Marco, Grüning Björn, Preissl Sebastian, Hortells Luis
衰老
细胞生物学
神经科学
成纤维细胞
发表日期：2025
文献求助 收藏

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

根据 BRCA1/2 突变类型和部位评估新诊断卵巢癌患者接受 PARP 抑制剂维持治疗的获益：一项多中心真实世界研究

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.104533
Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D
肿瘤
肿瘤免疫
卵巢癌
BRCA1
PARP
发表日期：2025
文献求助 收藏

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response

关于“根据BRCA1/2突变类型和部位评估PARP抑制剂维持治疗对新诊断卵巢癌患者的益处：一项多中心真实世界研究”的来信回复：并非所有BRCA突变都相同：功能背景和突变类型是PARP抑制剂疗效的共同决定因素

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105299
Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D
肿瘤
肿瘤免疫
卵巢癌
BRCA1
PARP
发表日期：2025
文献求助 收藏

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

回复关于“根据BRCA1/2突变类型和部位评估PARP抑制剂维持治疗对新诊断卵巢癌患者的益处：一项多中心真实世界研究”的来信

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105289
Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D
肿瘤
肿瘤免疫
卵巢癌
BRCA1
PARP
发表日期：2025
文献求助 收藏

Real-life observational study on niraparib in older patients with primary tubo-ovarian cancer: a focus on safety and efficacy

一项关于尼拉帕尼治疗老年原发性输卵管卵巢癌患者的真实世界观察性研究：重点关注安全性和有效性

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02914-y
Apostol, Adriana Ionelia; Bruno, Matteo; Sassu, Carolina Maria; Boccia, Serena Maria; Vertechy, Laura; Russo, Giorgia; Ruscito, Ilary; Capomacchia, Filippo Maria; Scambia, Giovanni; Fagotti, Anna; Marchetti, Claudia
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?

聚焦曲贝替定在卵巢癌中的应用：我们还需要了解什么？

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S451223
Boccia, Serena Maria; Sassu, Carolina Maria; Ergasti, Raffaella; Vertechy, Laura; Apostol, Adriana Ionelia; Palluzzi, Eleonora; Fagotti, Anna; Scambia, Giovanni; Marchetti, Claudia
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Corrigendum: Biosecurity measures to control hepatitis E virus on European pig farms

更正：控制欧洲养猪场戊型肝炎病毒的生物安全措施

期刊:Frontiers in Veterinary Science
影响因子:2.9
doi:10.3389/fvets.2024.1441544
Dubbert, Tamino; Meester, Marina; Smith, Richard Piers; Tobias, Tijs J; Di Bartolo, Ilaria; Johne, Reimar; Pavoni, Enrico; Krumova-Valcheva, Gergana; Sassu, Elena Lucia; Prigge, Christopher; Aprea, Giuseppe; May, Hannah; Althof, Nadine; Ianiro, Giovanni; Żmudzki, Jacek; Dimitrova, Albena; Alborali, Giovanni Loris; D'Angelantonio, Daniela; Scattolini, Silvia; Battistelli, Noemi; Burow, Elke
微生物学
肝炎
发表日期：2024
文献求助 收藏

Biosecurity measures to control hepatitis E virus on European pig farms

欧洲养猪场控制戊型肝炎病毒的生物安全措施

期刊:Frontiers in Veterinary Science
影响因子:2.9
doi:10.3389/fvets.2024.1328284
Dubbert, Tamino; Meester, Marina; Smith, Richard Piers; Tobias, Tijs J; Di Bartolo, Ilaria; Johne, Reimar; Pavoni, Enrico; Krumova-Valcheva, Gergana; Sassu, Elena Lucia; Prigge, Christopher; Aprea, Giuseppe; May, Hannah; Althof, Nadine; Ianiro, Giovanni; Żmudzki, Jacek; Dimitrova, Albena; Alborali, Giovanni Loris; D'Angelantonio, Daniela; Scattolini, Silvia; Battistelli, Noemi; Burow, Elke
微生物学
肝炎
发表日期：2024
文献求助 收藏

Biosecurity measures reducing Salmonella spp. and hepatitis E virus prevalence in pig farms-a systematic review and meta-analysis

降低猪场沙门氏菌和戊型肝炎病毒流行率的生物安全措施——系统评价和荟萃分析

期刊:Frontiers in Veterinary Science
影响因子:2.9
doi:10.3389/fvets.2024.1494870
Huber, Nikolaus; Meester, Marina; Sassu, Elena L; Waller, Elisabeth S L; Krumova-Valcheva, Gergana; Aprea, Giuseppe; D'Angelantonio, Daniela; Zoche-Golob, Veit; Scattolini, Silvia; Marriott, Emily; Smith, Richard P; Burow, Elke; Carreira, Guido Correia
微生物学
肝炎
发表日期：2024
文献求助 收藏